We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Analysts Say Disputed Merck Patents Will Need to Prove Enablement
Analysts Say Disputed Merck Patents Will Need to Prove Enablement
September 10, 2013
A patent lawsuit filed Aug. 30 by Gilead Sciences has analysts buzzing that its outcome will likely come down to U.S. patent laws’ enablement requirement.